ID

12784

Description

STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00376467

Lien

https://clinicaltrials.gov/show/NCT00376467

Mots-clés

  1. 21/12/2015 21/12/2015 -
Téléchargé le

21 décembre 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Acute Lymphoblastic Leukemia NCT00376467

Eligibility Acute Lymphoblastic Leukemia NCT00376467

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with ph +ve and/or bcr/abl +ve all, either in 1st chr (independently from the molecular status) for study a, or at diagnosis and untreated for study b;
Description

patients with ph +ve and/or bcr/abl +ve all

Type de données

boolean

Alias
UMLS CUI [1]
C0079011
UMLS CUI [2]
C1960397
age >18 years and <60 for study a, >60 for study b;
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
written voluntary informed consent.
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients of childbearing potential without a negative pregnancy test prior to the initiation of study. barrier contraceptive precautions are to be used throughout the trial in both sexes;
Description

patients of childbearing potential without a negative pregnancy test

Type de données

boolean

Alias
UMLS CUI [1]
C1960468
UMLS CUI [2]
C0549206
pretreatment with steroids for more than 10 days in study b;
Description

steroid therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0149783
serum bilirubin and creatinine values >3 the upper limit of normal range;
Description

serum bilirubin and creatinine

Type de données

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201976
sgot and sgpt values >3 the upper limit of the normal range;
Description

liver enzymes

Type de données

boolean

Alias
UMLS CUI [1]
C1860080
patients who had received any other investigational agent within 4 weeks before the enrollment;
Description

study subject participation status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
patients with cardiovascular diseases grade >3 according to the new york heart association (see appendix 1);
Description

cardiovascular diseases

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
patients with a history of non compliance to medical regimen or who are considered potentially unreliable;
Description

compliance behavior

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
patients with moderate/severe mood or psychiatric disorders;
Description

psychiatric disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0004936
concomitant neoplasia.
Description

malignancy

Type de données

boolean

Alias
UMLS CUI [1]
C0006826

Similar models

Eligibility Acute Lymphoblastic Leukemia NCT00376467

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
patients with ph +ve and/or bcr/abl +ve all
Item
patients with ph +ve and/or bcr/abl +ve all, either in 1st chr (independently from the molecular status) for study a, or at diagnosis and untreated for study b;
boolean
C0079011 (UMLS CUI [1])
C1960397 (UMLS CUI [2])
Age
Item
age >18 years and <60 for study a, >60 for study b;
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
written voluntary informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
patients of childbearing potential without a negative pregnancy test
Item
patients of childbearing potential without a negative pregnancy test prior to the initiation of study. barrier contraceptive precautions are to be used throughout the trial in both sexes;
boolean
C1960468 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
steroid therapy
Item
pretreatment with steroids for more than 10 days in study b;
boolean
C0149783 (UMLS CUI [1])
serum bilirubin and creatinine
Item
serum bilirubin and creatinine values >3 the upper limit of normal range;
boolean
C1278039 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
liver enzymes
Item
sgot and sgpt values >3 the upper limit of the normal range;
boolean
C1860080 (UMLS CUI [1])
study subject participation status
Item
patients who had received any other investigational agent within 4 weeks before the enrollment;
boolean
C2348568 (UMLS CUI [1])
cardiovascular diseases
Item
patients with cardiovascular diseases grade >3 according to the new york heart association (see appendix 1);
boolean
C0007222 (UMLS CUI [1])
compliance behavior
Item
patients with a history of non compliance to medical regimen or who are considered potentially unreliable;
boolean
C1321605 (UMLS CUI [1])
psychiatric disorders
Item
patients with moderate/severe mood or psychiatric disorders;
boolean
C0004936 (UMLS CUI [1])
malignancy
Item
concomitant neoplasia.
boolean
C0006826 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial